Acquisition Growth Morris & Dickson recently completed the acquisition of Prodigy Health and announced a planned LOI to acquire Prodigy Health, signaling an aggressive expansion strategy that opens cross-sell opportunities to Prodigy’s specialty and plasma derivative portfolios, as well as integrated distribution services.

New DC Expansion Plans to open a second distribution center in Olive Branch, Mississippi in early 2026 indicate capacity and regional coverage growth, creating opportunities to upsell enhanced logistics services, faster delivery, and expanded product availability to health systems and pharmacies in the Southeastern U.S.

Strategic Partnerships Active collaboration with Mark Cuban Cost Plus Drug Company to expand access to critical injectable medications nationwide presents a channel to partner on special pricing, formulary access programs, and bundled procurement for hospitals, clinics, and pharmacies.

Vertical Expansion Recent acquisition of Presa Solutions and a focus on specialty pharmaceutical distribution strengthens capabilities in niche therapeutic areas, enabling targeted sales pitches to specialty pharmacies, hospitals, and alternative care facilities seeking specialized injectable and plasma-derived products.

Technology & Scale With a robust tech stack (SAP, iCIMS, Zendesk, Sprout Social) and a large 12-acre automated distribution center, there is an opportunity to position M&D as a tech-enabled, reliable partner for next-day delivery and large SKUs, appealing to health systems prioritizing efficiency, compliance, and supplier modernization.